Trial Outcomes & Findings for Brain Imaging Changes in Fear and Anxiety (NCT NCT00047853)
NCT ID: NCT00047853
Last Updated: 2024-03-12
Results Overview
The average bed nucleus of the stria terminalis (BNST) correlations between all averaged time series were extracted from the raters' individual masks. Blood Oxygenation Level Dependent (BOLD) signals were used to extract a mean time series from the BNST masks. This time series was correlated across the rest of the brain using 3dTcorr1D, which computes the correlation coefficient between each voxel time series. Raters were blinded to subject identity for subjective sensory effects at high field and inter-rater and volume measurements for the drawn BNST masks. Correlations were calculated between average time series extracted between all raters' masks for each subject. Two separate analyses for the left and right BNSTs were performed.
COMPLETED
NA
1080 participants
10 minutes
2024-03-12
Participant Flow
15 participants were screen failure and two participants withdrew prior to start of study.
Participants had the option to volunteer for one or more sub-study
Participant milestones
| Measure |
Healthy Volunteers
Healthy volunteers participated in one or more sub-studies: Perception, Memory, Resting State, Passive Presentation, Loss Aversion Task, Motivation/reward, valence/salience study (ValSal Task)) and underwent Functional magnetic resonance imaging (fMRI) and/or magneto-encephalography (MEG).
|
Patients
Participants with diagnosis of generalized anxiety disorder (GAD), panic disorder, social anxiety disorder (SAD), specific phobia, posttraumatic stress disorder (PTSD), or major depression participated in one or more sub-studies: Perception, Memory, Resting State, Passive Presentation, Loss Aversion Task, Motivation/reward, valence/salience study (ValSal Task)) and underwent Functional magnetic resonance imaging (fMRI).
|
|---|---|---|
|
Overall Study Participants
STARTED
|
921
|
142
|
|
Overall Study Participants
COMPLETED
|
921
|
142
|
|
Overall Study Participants
NOT COMPLETED
|
0
|
0
|
|
Perception Study
STARTED
|
396
|
4
|
|
Perception Study
COMPLETED
|
396
|
4
|
|
Perception Study
NOT COMPLETED
|
0
|
0
|
|
Memory Study
STARTED
|
165
|
50
|
|
Memory Study
COMPLETED
|
165
|
50
|
|
Memory Study
NOT COMPLETED
|
0
|
0
|
|
Resting State Study
STARTED
|
218
|
57
|
|
Resting State Study
COMPLETED
|
218
|
57
|
|
Resting State Study
NOT COMPLETED
|
0
|
0
|
|
Passive Presentation Study
STARTED
|
57
|
0
|
|
Passive Presentation Study
COMPLETED
|
57
|
0
|
|
Passive Presentation Study
NOT COMPLETED
|
0
|
0
|
|
Loss Aversion Task
STARTED
|
14
|
22
|
|
Loss Aversion Task
COMPLETED
|
14
|
22
|
|
Loss Aversion Task
NOT COMPLETED
|
0
|
0
|
|
Motivation Task
STARTED
|
264
|
37
|
|
Motivation Task
COMPLETED
|
264
|
37
|
|
Motivation Task
NOT COMPLETED
|
0
|
0
|
|
Valence/Salience Study (ValSal Task)
STARTED
|
118
|
32
|
|
Valence/Salience Study (ValSal Task)
COMPLETED
|
118
|
32
|
|
Valence/Salience Study (ValSal Task)
NOT COMPLETED
|
0
|
0
|
|
Active Avoidance and Sustained Attention
STARTED
|
162
|
58
|
|
Active Avoidance and Sustained Attention
COMPLETED
|
162
|
58
|
|
Active Avoidance and Sustained Attention
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Analysis is a breakout of the two groups in the study
Baseline characteristics by cohort
| Measure |
Perception Study
n=400 Participants
Participants identified the expression on faces or identified the emotion of a word and were asked to respond during these stimuli themselves and during neutral pictures which were paired with these stimuli. Participants could also be asked to judge how long stimuli remained on the screen by making a button press denoting the relative duration of these stimuli compared to durations they learned.
|
Memory Study
n=147 Participants
Participants performed one or more memory tasks: a) navigated a virtual reality water maze with a joystick to learn the location of an escape platform; b) Behavioral Pattern Separation (BPS) task which consisted of two phases - first participants assign an indoor/outdoor verdict to pictures of neutral objects and completed a memory test. Lastly, participants were asked to remember verbal and nonverbal stimuli which consisted of words, pictures, letters or spatial locations in series of stimuli.
|
Resting State Study
n=243 Participants
Participants laid still with their eyes open and stared at a fixation cross for 6-9 minutes without falling asleep. During a resting state run, participants did not engage in any task. However, on some rest runs, they were under the threat of a shock or safe from shock.
|
Passive Presentation Study
n=4 Participants
Participants engaged in simple, passive experience (visual, auditory, tactile) to measure sensory responses under threat and safe conditions. Participants were asked to remain attentive to whether they were at risk of receiving shock or safe from shocks but did not need to respond to the stimuli.
|
Loss Aversion Task
n=13 Participants
Participants decided between taking or dismissing a series of monetary gambles.
|
Motivation Task (Monetary Incentive Delay (MID) Subjects)
n=197 Participants
Participants performed one of two versions of the MID task. The first version of the task examined the effect of threat of shock on goal driven/motivational stimuli where subjects made speeded responses to a central target under conditions of potential monetary gain, loss, or neutrality during threat of shock and during safety. During the second version, participants performed the MID task within the MRI scanner.
|
Valence/Salience Study (ValSal Task)
n=52 Participants
Participants completed the ValSal task involving two motivated behaviors, valence and salience. Valence compared the positive versus negative values tagged to stimuli/situations. Salience examined the subjective importance of stimuli/situations.
|
Active Avoidance and Sustained Attention Tasks
n=7 Participants
In the active avoidance signal task (AAST), participants performed a modified version of the threat paradigm during which, they held down a button and view sequentially presented pairs of colored squares and were instructed to lift their finger when they see the medium-medium color combination (i.e. "go" trials), and to refrain from lifting their finger during all other combinations (i.e. "stop" trials). Participants performed alternating blocks in safe and threat conditions, and each block consisted of a series of "go" and "stop" trials.
In the sustained attention to response task (SART), subjects participated in go/nogo during periods of threat of shocks and periods of safety, when no shock could be administered.
|
Total
n=1063 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|---|---|
|
Age, Categorical
Healthy Volunteers · <=18 years
|
0 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Age, Categorical
Healthy Volunteers · Between 18 and 65 years
|
396 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
97 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
190 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
187 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
36 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
7 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
921 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Age, Categorical
Healthy Volunteers · >=65 years
|
0 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Age, Categorical
Patients · <=18 years
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
—
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Age, Categorical
Patients · Between 18 and 65 years
|
4 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
50 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
53 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
—
|
9 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
10 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
16 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
142 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Age, Categorical
Patients · >=65 years
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
—
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Sex: Female, Male
Healthy Volunteers · Female
|
201 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
48 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
106 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
3 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
83 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
21 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
3 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
466 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Sex: Female, Male
Healthy Volunteers · Male
|
195 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
49 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
84 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
3 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
104 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
15 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
455 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Sex: Female, Male
Patients · Female
|
2 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
33 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
41 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
9 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
9 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
10 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
104 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Sex: Female, Male
Patients · Male
|
2 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
17 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
12 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
6 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
38 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Ethnicity (NIH/OMB)
Healthy Volunteers · Hispanic or Latino
|
21 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
5 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
21 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
15 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
67 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Ethnicity (NIH/OMB)
Healthy Volunteers · Not Hispanic or Latino
|
367 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
92 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
167 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
3 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
165 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
32 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
7 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
837 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Ethnicity (NIH/OMB)
Healthy Volunteers · Unknown or Not Reported
|
8 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
7 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
17 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Ethnicity (NIH/OMB)
Patients · Hispanic or Latino
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
7 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
13 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Ethnicity (NIH/OMB)
Patients · Not Hispanic or Latino
|
4 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
44 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
44 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
9 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
9 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
15 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
125 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Ethnicity (NIH/OMB)
Patients · Unknown or Not Reported
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
4 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · American Indian or Alaska Native
|
0 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · Asian
|
47 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
20 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
40 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
15 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
12 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
135 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · Black or African American
|
80 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
26 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
47 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
42 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
6 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
203 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · White
|
242 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
45 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
84 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
111 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
17 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
509 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · More than one race
|
8 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
8 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
24 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Healthy Volunteers · Unknown or Not Reported
|
19 Participants
n=396 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=97 Participants • Analysis is a breakout of the two groups in the study
|
10 Participants
n=190 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
15 Participants
n=187 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=36 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=7 Participants • Analysis is a breakout of the two groups in the study
|
47 Participants
n=921 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · American Indian or Alaska Native
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
1 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · Asian
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
5 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
3 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
12 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · Black or African American
|
2 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
11 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
10 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
1 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
1 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
29 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · White
|
2 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
28 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
30 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
4 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
8 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
9 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
81 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · More than one race
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
7 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
4 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
0 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
13 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
|
Race (NIH/OMB)
Patients · Unknown or Not Reported
|
0 Participants
n=4 Participants • Analysis is a breakout of the two groups in the study
|
2 Participants
n=50 Participants • Analysis is a breakout of the two groups in the study
|
3 Participants
n=53 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
1 Participants
n=9 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=10 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
n=16 Participants • Analysis is a breakout of the two groups in the study
|
0 Participants
Analysis is a breakout of the two groups in the study
|
6 Participants
n=142 Participants • Analysis is a breakout of the two groups in the study
|
PRIMARY outcome
Timeframe: 10 minutesPopulation: Analysis was done on a sample of healthy participants
The average bed nucleus of the stria terminalis (BNST) correlations between all averaged time series were extracted from the raters' individual masks. Blood Oxygenation Level Dependent (BOLD) signals were used to extract a mean time series from the BNST masks. This time series was correlated across the rest of the brain using 3dTcorr1D, which computes the correlation coefficient between each voxel time series. Raters were blinded to subject identity for subjective sensory effects at high field and inter-rater and volume measurements for the drawn BNST masks. Correlations were calculated between average time series extracted between all raters' masks for each subject. Two separate analyses for the left and right BNSTs were performed.
Outcome measures
| Measure |
Healthy Volunteers
n=27 Participants
Healthy volunteers underwent Functional magnetic resonance imaging (fMRI) and/or magneto-encephalography (MEG).
|
Healthy Volunteers - 7T fMRI
Healthy volunteers underwent 7T Functional magnetic resonance imaging (fMRI) and participated in go/nogo trial under threat of shock or no shock
|
|---|---|---|
|
Average Correlations Between Average Time Series - Left & Right Hemisphere of the Brain
Left BNST
|
0.9 correlation coefficient (r)
Standard Deviation 0.08
|
—
|
|
Average Correlations Between Average Time Series - Left & Right Hemisphere of the Brain
Right BNST
|
0.92 correlation coefficient (r)
Standard Deviation 0.07
|
—
|
PRIMARY outcome
Timeframe: 10 minutesPopulation: Analysis was done on a pilot sample of healthy volunteer participants
Images were acquired on a 7 T Siemens Magnetom MRI with a 32-channel head coil over 10 minutes. Participants were instructed to keep their eyes open and look at a white fixation cross on a black background during image acquisition. Following manual tracing of the habenula, the volumes of the left and right habenulae for each subject were computed separately. The left and right habenula volumes were then compared using a paired t-test.
Outcome measures
| Measure |
Healthy Volunteers
n=32 Participants
Healthy volunteers underwent Functional magnetic resonance imaging (fMRI) and/or magneto-encephalography (MEG).
|
Healthy Volunteers - 7T fMRI
Healthy volunteers underwent 7T Functional magnetic resonance imaging (fMRI) and participated in go/nogo trial under threat of shock or no shock
|
|---|---|---|
|
Difference in Volume - Left & Right Habenula
Left Habenula
|
18.8 mm^3
Standard Deviation 6
|
—
|
|
Difference in Volume - Left & Right Habenula
Right Habenula
|
14.9 mm^3
Standard Deviation 4
|
—
|
PRIMARY outcome
Timeframe: 2000 milliseconds during trialPopulation: Analysis included only participants who completed the Sustained Attention to Response Task (SART)
Subjects participated in go/nogo (91% GO trials with the " = " symbol indicating button push and 9% NOGO trials with the "O" symbol indicating no push)) task condition during 3 Tesla (3T) or 7 Tesla (7T) functional MRI with periods of threat of shocks and periods of safety when no shock could be administered. During the GNG stimuli were presented on a monitor and randomly distributed. A correct go hit was a response recorded during these 2000 ms to a go trial. Similarly, a correct nogo omission was a no response during the same period to a nogo trial. Performance was first averaged across condition (threat, safe) and trial type (go, nogo) by dividing the number of correct responses by the total number of each trial type. The NOGO and GO behavioral effects were then separately compared between 3T and 7T strength. Accuracy was measured as a percent of correct button presses during fMRI (3T or 7T).
Outcome measures
| Measure |
Healthy Volunteers
n=31 Participants
Healthy volunteers underwent Functional magnetic resonance imaging (fMRI) and/or magneto-encephalography (MEG).
|
Healthy Volunteers - 7T fMRI
n=31 Participants
Healthy volunteers underwent 7T Functional magnetic resonance imaging (fMRI) and participated in go/nogo trial under threat of shock or no shock
|
|---|---|---|
|
Percent of Correct No Button Presses During Functional MRI
NOGO Trials
|
71 Percentage of accurate responses
Standard Deviation 20
|
76 Percentage of accurate responses
Standard Deviation 15
|
|
Percent of Correct No Button Presses During Functional MRI
GO Trials
|
99 Percentage of accurate responses
Standard Deviation 3
|
95 Percentage of accurate responses
Standard Deviation 7
|
Adverse Events
Perception Study - Healthy Volunteer
Perception Study - Patient
Memory Study - Healthy Volunteer
Memory Study - Patient
Resting State Study - Healthy Volunteer
Resting State Study - Patient
Passive Presentation Study - Healthy Volunteer
Loss Aversion Task - Healthy Volunteer
Loss Aversion Task - Patient
Motivation Task (Monetary Incentive Delay (MID) Study) - Healthy Volunteer
Motivation Task (Monetary Incentive Delay (MID) Study) - Patient
Valence/Salience Study (ValSal Task) - Healthy Volunteer
Valence/Salience Study (ValSal Task) - Patient
Active Avoidance and Sustained Attention Tasks - Healthy Volunteer
Active Avoidance and Sustained Attention Tasks - Patient
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place